Marius Pharmaceuticals has backed a move by the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) to update prescribing information for testosterone ...

The US Department of Health and Human Services wants to remove some of the stigma from testosterone treatment.

The US Department of Health and Human Services is requesting revisions to the labels on testosterone replacement therapies ...

Since then, a large study known as the TRAVERSE trial followed more than 5,200 men and found no meaningful rise in major ...

But on June 18, the U.S. Department of Health and Human Services (HHS) announced that it is requesting updates to ...

It may soon get easier for older men to get ahold of testosterone therapy. On Thursday, the Department of Health and Human ...

Men with low testosterone will soon have greater access to hormone replacement therapy following new changes to product ...

The FDA’s second major labeling update in 16 months — after its February 2025 removal of the cardiovascular boxed warning — marks a historic ...

The Department of Health and Human Services (HHS) announced plans on June 18 to update label information for testosterone ...

Federal health officials said testosterone therapy warning labels could be updated after a review found current evidence did ...

Younger Americans are falling behind on cancer screenings, testosterone therapy warnings may soon change and a rare amoeba ...

The US Food and Drug Administration (FDA) yesterday said it will require manufacturers of testosterone products about an increased risk of venous blood clots, known as venous thromboembolism (VTE)—the ...